|
市場調查報告書
全球末梢血管設備的競爭動向：2008年
Global Competitor Insights for Peripheral Vascular Disease 2008
|
全球末梢血管設備的競爭動向：2008年 是由出版商Millennium Research Group在2008年06月所出版的。
這份英文市場調查報告書價格從美金4197起跳。
本報告書內容包括：全球末梢血管設備市場的動向及美國、歐洲、日本地區別動向、進入市場中各家企業的末梢血管設備概要等。內容綱要摘記如下：
實施概要
方法論
第1章 全球末梢血管設備市場
第2章 CORDIS (Johnson & Johnson)
第3章 Boston Scientific
第4章 W. L. GORE
第5章 COOK MEDICAL
第6章 ABBOTT VASCULAR
第7章 C.R. BARD
第8章 MEDTRONIC
第9章 TERIMO MEDICAL
第10章 0EV3
附錄
Abstract
MRG' s Global Competitor Insights for Peripheral Vascular Devices 2008 report
covers the US, Europe (France, Germany, Italy, and the UK), and Japan, and
includes PV stents, percutaneous transluminal angioplasty (PTA) balloon
catheters, embolic protection devices (EPDs), inferior vena cava filters
(IVCFs), aortic stent grafts, and PV accessory devices.
Millennium Research Group' s (MRG) Global Competitor Insights for Peripheral
Vascular Devices 2008 report provides an in depth analysis of each of the top
nine competitors in the global peripheral vascular (PV) device market. This
report serves as a tool for evaluating each company' s performance relative to
its competitors.
Table of Contents
EXECUTIVE SUMMARY
METHODOLOGY
1.0 GLOBAL PERIPHERAL VASCULAR DEVICE MARKET
- 1.1 Market Overview
- 1.1.1 Procedures
- 1.1.2 Peripheral Vascular Devices
- 1.1.2.1 Peripheral Vascular Stents
- 1.1.2.2 Percutaneous Transluminal Angioplasty Balloon Catheters
- 1.1.2.3 Embolic Protection Devices
- 1.1.2.4 Inferior Vena Cava Filters
- 1.1.2.5 Aortic Stent Grafts
- 1.1.2.6 Peripheral Vascular Accessory Devices
- 1.2 Regional Analysis
- 1.2.1 Global Analysis
- 1.2.2 US Analysis
- 1.2.3 Europe Analysis
- 1.2.4 Japan Analysis
2.0 CORDIS (JOHNSON & JOHNSON)
- 2.1 Company Overview
- 2.1.1 Recent Events
- 2.1.2 Company Analysis
- 2.1.3 S.W.O.T. Analysis
- 2.1.3.1 Strengths
- 2.1.3.2 Weaknesses
- 2.1.3.3 Opportunities
- 2.1.3.4 Threats
- 2.2 Peripheral Vascular Device Profile
- 2.2.1 Peripheral Vascular Stent Summary
- 2.2.2 PTA Balloon Catheter Summary
- 2.2.3 Embolic Protection Device Summary
- 2.2.4 Inferior Vena Cava Filter Summary
- 2.2.5 Peripheral Vascular Accessory Device Summary
3.0 BOSTON SCIENTIFIC
- 3.1 Company Overview
- 3.1.1 Recent Events
- 3.1.2 Company Analysis
- 3.1.3 S.W.O.T. Analysis
- 3.1.3.1 Strengths
- 3.1.3.2 Weaknesses
- 3.1.3.3 Opportunities
- 3.1.3.4 Threats
- 3.2 Peripheral Vascular Device Profile
- 3.2.1 Peripheral Vascular Stent Summary
- 3.2.2 PTA Balloon Catheter Summary
- 3.2.3 Embolic Protection Device Summary
- 3.2.4 Inferior Vena Cava Filter Summary
- 3.2.5 Peripheral Vascular Accessory Device Summary
4.0 W.L. GORE
- 4.1 Company Overview
- 4.1.1 Recent Events
- 4.1.2 Company Analysis
- 4.1.3 S.W.O.T. Analysis
- 4.1.3.1 Strengths
- 4.1.3.2 Weaknesses
- 4.1.3.3 Opportunities
- 4.1.3.4 Threats
- 4.2 Peripheral Vascular Device Profile
- 4.2.1 Peripheral Vascular Stent Device Summary
- 4.2.2 Embolic Protection Device Summary
- 4.2.3 Aortic Stent Graft Summary
5.0 COOK MEDICAL
- 5.1 Company Overview
- 5.1.1 Recent Events
- 5.1.2 Company Analysis
- 5.1.3 S.W.O.T. Analysis
- 5.1.3.1 Strengths
- 5.1.3.2 Weaknesses
- 5.1.3.3 Opportunities
- 5.1.3.4 Threats
- 5.2 Peripheral Vascular Device Profile
- 5.2.1 Peripheral Vascular Stent Summary
- 5.2.2 PTA Balloon Catheter Summary
- 5.2.3 Inferior Vena Cava Filter Summary
- 5.2.4 Aortic Stent Graft Summary
- 5.2.5 Peripheral Vascular Accessory Device Summary
6.0 ABBOTT VASCULAR
- 6.1 Company Overview
- 6.1.1 Recent Events
- 6.1.2 Company Analysis
- 6.1.3 S.W.O.T. Analysis
- 6.1.3.1 Strengths
- 6.1.3.2 Weaknesses
- 6.1.3.3 Opportunities
- 6.1.3.4 Threats
- 6.2 Peripheral Vascular Device Profile
- 6.2.1 Peripheral Vascular Stent Device Summary
- 6.2.2 PTA Balloon Catheter Summary
- 6.2.3 Embolic Protection Device Summary
- 6.2.4 Peripheral Vascular Accessory Device Summary
7.0 C. R. BARD
- 7.1 Company Overview
- 7.1.1 Recent Events
- 7.1.2 Company Analysis
- 7.1.3 S.W.O.T. Analysis
- 7.1.3.1 Strengths
- 7.1.3.2 Weaknesses
- 7.1.3.3 Opportunities
- 7.1.3.4 Threats
- 7.2 Peripheral Vascular Device Profile
- 7.2.1 Peripheral Vascular Stent Summary
- 7.2.2 PTA Balloon Catheter Summary
- 7.2.3 Inferior Vena Cava Filter Summary
8.0 MEDTRONIC
- 8.1 Company Overview
- 8.1.1 Recent Events
- 8.1.2 Company Analysis
- 8.1.3 S.W.O.T. Analysis
- 8.1.3.1 Strengths
- 8.1.3.2 Weaknesses
- 8.1.3.3 Opportunities
- 8.1.3.4 Threats
- 8.2 Peripheral Vascular Device Profile
- 8.2.1 Peripheral Vascular Stent Summary
- 8.2.2 Embolic Protection Device Summary
- 8.2.3 Aortic Stent Graft Summary
9.0 TERUMO MEDICAL
- 9.1 Company Overview
- 9.1.1 Recent Events
- 9.1.2 Company Analysis
- 9.1.3 S.W.O.T. Analysis
- 9.1.3.1 Strengths
- 9.1.3.2 Weaknesses
- 9.1.3.3 Opportunities
- 9.1.3.4 Threats
- 9.2 Peripheral Vascular Device Profile
- 9.2.1 Aortic Stent Graft Device Summary
- 9.2.2 Peripheral Vascular Accessory Device Summary
10.0 EV3
- 10.1 Company Overview
- 10.1.1 Recent Events
- 10.1.2 Company Analysis
- 10.1.3 S.W.O.T. Analysis
- 10.1.3.1 Strengths
- 10.1.3.2 Weaknesses
- 10.1.3.3 Opportunities
- 10.1.3.4 Threats
- 10.2 Peripheral Vascular Device Profile
- 10.2.1 Peripheral Vascular Stent Summary
- 10.2.2 PTA Balloon Catheter Summary
- 10.2.3 Embolic Protection Device Summary
- 10.2.4 Peripheral Vascular Accessory Device Summary
APPENDIX A: MRG ACRONYMS AND INITIALISMS
|
